ALPS Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.56M | Buy |
49,775
+16,072
| +48% | +$1.41M | 0.02% | 301 |
|
|
2026
Q1 | $2.87M | Sell |
33,703
-7,937
| -19% | -$707K | 0.01% | 340 |
|
|
2025
Q4 | $3.29M | Sell |
41,640
-173
| -0.4% | -$13.6K | 0.02% | 313 |
|
|
2025
Q3 | $3.34M | Buy |
41,813
+8,238
| +25% | +$703K | 0.02% | 304 |
|
|
2025
Q2 | $3.05M | Sell |
33,575
-98
| -0.3% | -$8.95K | 0.02% | 302 |
|
|
2025
Q1 | $3.16M | Buy |
33,673
+899
| +3% | +$80.5K | 0.02% | 288 |
|
|
2024
Q4 | $2.98M | Sell |
32,774
-98
| -0.3% | -$9.35K | 0.02% | 289 |
|
|
2024
Q3 | $3.41M | Buy |
32,872
+4,723
| +17% | +$481K | 0.02% | 282 |
|
|
2024
Q2 | $2.73M | Sell |
28,149
-17
| -0.1% | -$1.57K | 0.02% | 297 |
|
|
2024
Q1 | $2.54M | Buy |
28,166
+4,260
| +18% | +$361K | 0.02% | 316 |
|
|
2023
Q4 | $1.91M | Buy |
23,906
+120
| +0.5% | +$9.02K | 0.02% | 336 |
|
|
2023
Q3 | $1.69M | Sell |
23,786
-9,684
| -29% | -$724K | 0.01% | 346 |
|
|
2023
Q2 | $2.58M | Sell |
33,470
-842
| -2% | -$65.2K | 0.02% | 269 |
|
|
2023
Q1 | $2.58M | Sell |
34,312
-18,536
| -35% | -$1.38M | 0.02% | 248 |
|
|
2022
Q4 | $4.16M | Sell |
52,848
-5,255
| -9% | -$394K | 0.04% | 190 |
|
|
2022
Q3 | $4.08M | Sell |
58,103
-58,380
| -50% | -$4.58M | 0.04% | 192 |
|
|
2022
Q2 | $9.34M | Buy |
116,483
+95,569
| +457% | +$7.47M | 0.09% | 149 |
|
|
2022
Q1 | $1.59M | Sell |
20,914
-3,187
| -13% | -$252K | 0.02% | 269 |
|
|
2021
Q4 | $2.06M | Sell |
24,101
-3,122
| -11% | -$244K | 0.02% | 287 |
|
|
2021
Q3 | $2.06M | Sell |
27,223
-5,591
| -17% | -$444K | 0.02% | 314 |
|
|
2021
Q2 | $2.67M | Sell |
32,814
-1,370
| -4% | -$112K | 0.02% | 245 |
|
|
2021
Q1 | $2.69M | Sell |
34,184
-3,937
| -10% | -$309K | 0.03% | 229 |
|
|
2020
Q4 | $3.26M | Sell |
38,121
-2,526
| -6% | -$209K | 0.04% | 207 |
|
|
2020
Q3 | $3.14M | Sell |
40,647
-3,323
| -8% | -$253K | 0.05% | 189 |
|
|
2020
Q2 | $3.22M | Buy |
43,970
+7,663
| +21% | +$544K | 0.04% | 189 |
|
|
2020
Q1 | $2.41M | Buy |
36,307
+26,059
| +254% | +$1.84M | 0.04% | 193 |
|
|
2019
Q4 | $705K | Sell |
10,248
-724
| -7% | -$49.4K | 0.01% | 461 |
|
|
2019
Q3 | $807K | Sell |
10,972
-4,152
| -27% | -$301K | 0.01% | 343 |
|
|
2019
Q2 | $1.08M | Sell |
15,124
-960
| -6% | -$68.1K | 0.01% | 313 |
|
|
2019
Q1 | $1.1M | Buy |
+16,084
| New | +$1.04M | 0.01% | 305 |
|
Other funds holding CL
ALPS Advisors's CL Position: Q2 2026 in Review
ALPS Advisors increased its Colgate-Palmolive (CL) stake by 48% in Q2 2026, buying an estimated $1.41M and bringing the position to 49,775 shares worth $4.56M. The position accounts for 0.02% of the portfolio, ranked #301.
ALPS Advisors first reported a position in CL in Q1 2019 and has held it in 30 quarters since. The position peaked at $9.34M in Q2 2022. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- ALPS Advisors held 49,775 shares of Colgate-Palmolive worth $4.56M as of Q2 2026.
- ALPS Advisors bought 16,072 Colgate-Palmolive shares in Q2 2026, an estimated $1.41M.
- Colgate-Palmolive made up 0.02% of ALPS Advisors's portfolio in Q2 2026, its #301 holding.
- ALPS Advisors first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 30 quarters since.
- ALPS Advisors's Colgate-Palmolive position peaked at $9.34M in Q2 2022.
- 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.